cells in the pancreas, resulting in failure of blood glucose regulation and devastating
secondary complications. Thus, β-cells are currently the prime target for cell-replacement
and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-
cell mass and normoglycemia in diabetic patients. Potential strategies include targeting
specific β-cell subpopulations to increase proliferation or maturation. Alternatively …